Skip to Content
You are currently on the new version of our website. Access the old version .
AntioxidantsAntioxidants
  • Review
  • Open Access

24 June 2017

9 Pages

Vitamin E and Alzheimer’s Disease—Is It Time for Personalized Medicine?

and
Ursuline College, Pepper Pike, OH 44121, USA
*
Author to whom correspondence should be addressed.

Abstract

For the last two decades, it has been hotly debated whether vitamin E—the major lipid-soluble antioxidant, which functions to maintain neurological integrity—is efficacious as a therapy for Alzheimer’s disease. Several factors key to the debate, include (1) which of the eight naturally-occurring vitamin E forms should be used; (2) how combination treatments affect vitamin E efficacy; and (3) safety concerns that most-recently resurfaced after the results of the Selenium and vitamin E Cancer prevention trial SELECT prostate cancer trial. However, with the advent of new genetic technologies and identifications of vitamin E-modulating single nucleotide polymorphisms (SNPs), we propose that clinical trials addressing the question “Is vitamin E an effective treatment for Alzheimer’s disease” should consider a more focused and personalized medicine approach to designing experiments. An individual’s naturally-occurring SNP variants may indeed influence vitamin E’s therapeutic effect on Alzheimer’s disease.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.